(A) Share of identified genes, which are ignored (never tagged, blue) or tagged (at least once) within the COVID-19 literature. (B) Share of tagged genes identified by a single (orange) or multiple …
Share of identified genes, which are ignored (never tagged, blue) or tagged at least once (red) within the COVID-19 literature after additionally including genes occurring in abstracts of preprints.
Percentage of genes with indicated levels of support by the four genome-wide studies which have been tagged at least once in the COVID-19 literature. (A) Analysis restricted to the 50% of genes with …
(A) Drugs studied in COVID-19 related clinical trials are frequently studied within the non-COVID-19 literature. We compare non-COVID-19 publications measured for human protein-coding genes that are …
Source code for curation and analysis of datasets.
Gene Ontology enrichment analysis for human protein-coding genes tagged in the COVID-19 literature.
Identification of genes through multiple GWAS comparisons.
Implicated host genes identified by multiple genome-wide studies.
Extent of tags in COVID-19 literature compared to rate identification in genome-wide datasets.
Per-gene average share of COVID-19 literature and per-gene average identification rate in genome-wide datasets (one if identified, 0 if not identified). Shown are the ratios of this share and the rates in individual groups (100 first tagged genes, and 20% top-tagged genes) over the share and the rates of the other genes that have been tagged in the COVID-19 literature.
Number of laboratories working on individual genes, identified within one of the four genome-wide datasets, between 2006 and 2015.